Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis
Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites withou...
Saved in:
| Published in | American journal of physiology. Lung cellular and molecular physiology Vol. 300; no. 1; pp. L4 - L11 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Physiological Society
01.01.2011
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply ¹H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) (ρ = -0.53, P = 0.05, q = 0.25) and ventilator-free days (ρ = -0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS (ρ = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma ¹H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients. |
|---|---|
| AbstractList | Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply ¹H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) (ρ = -0.53, P = 0.05, q = 0.25) and ventilator-free days (ρ = -0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS (ρ = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma ¹H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients.Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply ¹H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) (ρ = -0.53, P = 0.05, q = 0.25) and ventilator-free days (ρ = -0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS (ρ = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma ¹H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients. Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply 1 H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) (ρ = −0.53, P = 0.05, q = 0.25) and ventilator-free days (ρ = −0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS (ρ = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma 1 H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients. Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply ¹H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) (ρ = -0.53, P = 0.05, q = 0.25) and ventilator-free days (ρ = -0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS (ρ = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma ¹H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients. Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant biomarkers. Nuclear magnetic resonance (NMR) spectroscopy allows for establishing quantitative data sets for multiple endogenous metabolites without preconception. Sepsis-induced acute lung injury (ALI) is a complex and serious illness associated with high morbidity and mortality for which there is presently no effective pharmacotherapy. The goal of this study was to apply 1H-NMR based quantitative metabolomics with subsequent computational analysis to begin working towards elucidating the plasma metabolic changes associated with sepsis-induced ALI. To this end, this pilot study generated quantitative data sets that revealed differences between patients with ALI and healthy subjects in the level of the following metabolites: total glutathione, adenosine, phosphatidylserine, and sphingomyelin. Moreover, myoinositol levels were associated with acute physiology scores (APS) ( rho = -0.53, P = 0.05, q = 0.25) and ventilator-free days ( rho = -0.73, P = 0.005, q = 0.01). There was also an association between total glutathione and APS ( rho = 0.56, P = 0.04, q = 0.25). Computational network analysis revealed a distinct metabolic pathway for each metabolite. In summary, this pilot study demonstrated the feasibility of plasma 1H-NMR quantitative metabolomics because it yielded a physiologically relevant metabolite data set that distinguished sepsis-induced ALI from health. In addition, it justifies the continued study of this approach to determine whether sepsis-induced ALI has a distinct metabolic phenotype and whether there are predictive biomarkers of severity and outcome in these patients. |
| Author | Serkova, Natalie J Paine, 3rd, Robert Karnovsky, Alla Standiford, Theodore J Stringer, Kathleen A Guire, Kenneth |
| Author_xml | – sequence: 1 givenname: Kathleen A surname: Stringer fullname: Stringer, Kathleen A email: stringek@umich.edu organization: Dept. of Clinical, Social, and Administrative Sciences, Univ. of Michigan, Ann Arbor, 48109-1065, USA. stringek@umich.edu – sequence: 2 givenname: Natalie J surname: Serkova fullname: Serkova, Natalie J – sequence: 3 givenname: Alla surname: Karnovsky fullname: Karnovsky, Alla – sequence: 4 givenname: Kenneth surname: Guire fullname: Guire, Kenneth – sequence: 5 givenname: Robert surname: Paine, 3rd fullname: Paine, 3rd, Robert – sequence: 6 givenname: Theodore J surname: Standiford fullname: Standiford, Theodore J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20889676$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU1uFDEQhS0URH7gAiyQd6x68M_Y7t4goQiSSEFsYN2qdlcPHrntTtseaY7DMdhyMhwloLBiVaV6T189VZ2TkxADEvKasw3nSryD_eJL2G0YE5JvBOPsGTmrgmi4YtuTJ_0pOU9pzxhTjOkX5FSwtu200Wfkx2fMMETvLLUxJLwrGCwmGieacEkuNS6MxeJIwZaM9H4hdWFf1iNd8YDgqzQc6eIhzUB__bxuQrEeYaUz7ALmCl4xxQAVS-8KhOwyZHdAOj9sjrOziUIYa4B5Kfdidfs6AX-sAV6S5xP4hK8e6wX59unj18vr5vbL1c3lh9tmEcLkxmjGJzCjUR0MKEc-yU5zmPikleq2CoSVkmk-Sq2RTYAKWithnBQbDOcoL8j7B-5ShhlHiyGv4PtldTOsxz6C6_9Vgvve7-Khl_X8opMV8PYRsMZ6xpT72SWL3kPAWFLfGsGF6fj2_07BTGvkllfnm6eh_qb580D5G9yqp44 |
| ContentType | Journal Article |
| Copyright | Copyright © 2011 the American Physiological Society |
| Copyright_xml | – notice: Copyright © 2011 the American Physiological Society |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 7QL 7U7 C1K 5PM |
| DOI | 10.1152/ajplung.00231.2010 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Toxicology Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry Biology |
| EISSN | 1522-1504 |
| EndPage | L11 |
| ExternalDocumentID | PMC3023293 20889676 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: P50 HL074024 – fundername: NCRR NIH HHS grantid: UL1 RR025780 – fundername: NHLBI NIH HHS grantid: P50-HL-074924 – fundername: NCI NIH HHS grantid: P30 CA046934 – fundername: NCI NIH HHS grantid: P30-CA-046934 – fundername: NCRR NIH HHS grantid: UL1-RR-025780 |
| GroupedDBID | --- 23M 2WC 39C 4.4 53G 5GY 5VS 8M5 ACPRK ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BKOMP BTFSW C1A CGR CUY CVF E3Z EBS ECM EIF EJD EMOBN F5P H13 ITBOX KQ8 NPM OK1 P2P PQQKQ RAP RHI RPL RPRKH TR2 W8F WH7 WOQ XSW YSK 7X8 7QL 7U7 C1K 5PM |
| ID | FETCH-LOGICAL-p227t-7601fa7d759abe3d1f3961af1f655945a2c33061d366e0fae5a8c3adf50b711e3 |
| ISSN | 1522-1504 1040-0605 |
| IngestDate | Thu Aug 21 14:20:40 EDT 2025 Fri Jul 11 08:42:49 EDT 2025 Thu Jul 10 18:10:56 EDT 2025 Thu Apr 03 07:02:17 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p227t-7601fa7d759abe3d1f3961af1f655945a2c33061d366e0fae5a8c3adf50b711e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 K. A. Stringer and N. J. Serkova contributed equally to this work. |
| PMID | 20889676 |
| PQID | 820787341 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3023293 proquest_miscellaneous_872127914 proquest_miscellaneous_820787341 pubmed_primary_20889676 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-01-01 |
| PublicationDateYYYYMMDD | 2011-01-01 |
| PublicationDate_xml | – month: 01 year: 2011 text: 2011-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Bethesda, MD |
| PublicationTitle | American journal of physiology. Lung cellular and molecular physiology |
| PublicationTitleAlternate | Am J Physiol Lung Cell Mol Physiol |
| PublicationYear | 2011 |
| Publisher | American Physiological Society |
| Publisher_xml | – name: American Physiological Society |
| References | 20139469 - Bioinformatics. 2010 Apr 1;26(7):971-3 16680201 - Metabolomics. 2005 Mar;1(1):3-9 18179359 - Antioxid Redox Signal. 2008 Apr;10(4):739-53 20228181 - Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L755-67 8989170 - Crit Care Med. 1997 Jan;25(1):9-15 15698456 - Kidney Int. 2005 Mar;67(3):1142-51 7316475 - Ann Hum Genet. 1981 Feb;45(Pt 1):15-9 18658106 - Am J Respir Crit Care Med. 2008 Oct 1;178(7):701-9 19428331 - Biochem Pharmacol. 2009 Jun 15;77(12):1763-72 19480633 - Biotechniques. 2009 Apr;46(5):363-5 16909368 - Semin Respir Crit Care Med. 2006 Aug;27(4):337-49 12120097 - Nat Rev Drug Discov. 2002 Feb;1(2):153-61 15627238 - NMR Biomed. 2005 May;18(3):143-62 11706287 - Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):521-6 9700100 - Am J Physiol. 1998 Aug;275(2 Pt 1):L379-88 11706283 - Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):499-502 12091165 - Am J Respir Crit Care Med. 2002 Jul 1;166(1):16-20 18403332 - Proc Am Thorac Soc. 2008 Apr 15;5(3):348-53 18755926 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1100-14 7509706 - Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24 18953024 - Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10 18760298 - Mol Aspects Med. 2009 Feb-Apr;30(1-2):60-76 18171018 - Chem Res Toxicol. 2008 Jan;21(1):9-27 19835422 - J Proteome Res. 2009 Dec;8(12):5423-30 18441091 - Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L152-61 19201926 - Am J Respir Crit Care Med. 2009 May 1;179(9):806-15 19948758 - Nucleic Acids Res. 2010 Jan;38(Database issue):D480-7 15789454 - Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R247-9 17016518 - Mol Syst Biol. 2006;2:52 19864339 - Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R166-72 17900487 - Crit Care Clin. 2007 Jul;23(3):639-58 12324551 - N Engl J Med. 2002 Sep 26;347(13):966-7 17882155 - Mol Syst Biol. 2007;3:135 16222040 - Proc Am Thorac Soc. 2005;2(3):214-20 12133657 - Lancet. 2002 Jul 20;360(9328):219-23 17202168 - Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 20479934 - PLoS One. 2010;5(5):e10538 20457745 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W71-7 17396131 - Cell Death Differ. 2007 Jul;14(7):1315-23 18020967 - Clin Chem Lab Med. 2008;46(1):27-42 17009906 - Expert Rev Mol Diagn. 2006 Sep;6(5):717-31 17360481 - Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4083-8 18203816 - Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L632-41 19494329 - J Immunol. 2009 Jun 15;182(12):8037-46 |
| References_xml | – reference: 18658106 - Am J Respir Crit Care Med. 2008 Oct 1;178(7):701-9 – reference: 19480633 - Biotechniques. 2009 Apr;46(5):363-5 – reference: 17016518 - Mol Syst Biol. 2006;2:52 – reference: 18171018 - Chem Res Toxicol. 2008 Jan;21(1):9-27 – reference: 16680201 - Metabolomics. 2005 Mar;1(1):3-9 – reference: 19201926 - Am J Respir Crit Care Med. 2009 May 1;179(9):806-15 – reference: 20139469 - Bioinformatics. 2010 Apr 1;26(7):971-3 – reference: 15789454 - Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R247-9 – reference: 17009906 - Expert Rev Mol Diagn. 2006 Sep;6(5):717-31 – reference: 18953024 - Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10 – reference: 8989170 - Crit Care Med. 1997 Jan;25(1):9-15 – reference: 11706287 - Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):521-6 – reference: 11706283 - Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):499-502 – reference: 19948758 - Nucleic Acids Res. 2010 Jan;38(Database issue):D480-7 – reference: 19494329 - J Immunol. 2009 Jun 15;182(12):8037-46 – reference: 18441091 - Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L152-61 – reference: 7509706 - Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24 – reference: 20228181 - Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L755-67 – reference: 17202168 - Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 – reference: 17360481 - Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4083-8 – reference: 18179359 - Antioxid Redox Signal. 2008 Apr;10(4):739-53 – reference: 18403332 - Proc Am Thorac Soc. 2008 Apr 15;5(3):348-53 – reference: 9700100 - Am J Physiol. 1998 Aug;275(2 Pt 1):L379-88 – reference: 18755926 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1100-14 – reference: 17396131 - Cell Death Differ. 2007 Jul;14(7):1315-23 – reference: 19835422 - J Proteome Res. 2009 Dec;8(12):5423-30 – reference: 12133657 - Lancet. 2002 Jul 20;360(9328):219-23 – reference: 20457745 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W71-7 – reference: 17900487 - Crit Care Clin. 2007 Jul;23(3):639-58 – reference: 15698456 - Kidney Int. 2005 Mar;67(3):1142-51 – reference: 7316475 - Ann Hum Genet. 1981 Feb;45(Pt 1):15-9 – reference: 16909368 - Semin Respir Crit Care Med. 2006 Aug;27(4):337-49 – reference: 19864339 - Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R166-72 – reference: 12091165 - Am J Respir Crit Care Med. 2002 Jul 1;166(1):16-20 – reference: 12324551 - N Engl J Med. 2002 Sep 26;347(13):966-7 – reference: 17882155 - Mol Syst Biol. 2007;3:135 – reference: 19428331 - Biochem Pharmacol. 2009 Jun 15;77(12):1763-72 – reference: 15627238 - NMR Biomed. 2005 May;18(3):143-62 – reference: 18203816 - Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L632-41 – reference: 18760298 - Mol Aspects Med. 2009 Feb-Apr;30(1-2):60-76 – reference: 12120097 - Nat Rev Drug Discov. 2002 Feb;1(2):153-61 – reference: 20479934 - PLoS One. 2010;5(5):e10538 – reference: 16222040 - Proc Am Thorac Soc. 2005;2(3):214-20 – reference: 18020967 - Clin Chem Lab Med. 2008;46(1):27-42 |
| SSID | ssj0005006 |
| Score | 2.3856096 |
| Snippet | Metabolomics is an emerging component of systems biology that may be a viable strategy for the identification and validation of physiologically relevant... |
| SourceID | pubmedcentral proquest pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | L4 |
| SubjectTerms | Acute Lung Injury - blood Acute Lung Injury - pathology Humans Magnetic Resonance Spectroscopy - methods Metabolomics - methods Metabolomics - trends Phenotype Pilot Projects Reference Values Sepsis - blood Sepsis - complications Sepsis - genetics |
| Title | Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20889676 https://www.proquest.com/docview/820787341 https://www.proquest.com/docview/872127914 https://pubmed.ncbi.nlm.nih.gov/PMC3023293 |
| Volume | 300 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIgQXBC2P8NIeKJfIxa-142MatYpoWkBKpN6sjb1bWohtErtS-Tf8DK78Ef4KM7tex6ERr4tl2St75fk8-83sPAh56QYi9d0ktWzpcstPubT6Uehasi-APDiyL23Mdz4-CUZT_80pO-10frSilqpytpd82ZhX8j9ShWsgV8yS_QfJNg-FC3AO8oUjSBiOfyXjY1GCDLFMddIKikb-txTF8nxpgcFd4QY_TzAc4FOl8lcu4DNiygpSREU_C2DQc97bHbq7-9HIyrDEMV_05vwsE7rEM_J11ACfK56prDSMN5rrt2Na89KkxxVVabyLvC530qa_zf5Qq2CF8q0o5_5eb4wzxL0EFRyLz5yb9r2tcY1XqNROyXZUyMo3C1rwY37J9RKCdR7FagvsiC-y_LL2Gw903yUdhmTS3up8pbZTRKUGGqdIrcfBxgauq30VYsO1Wvl7tn0N5VqVj_3NKwzDirX8okCZoTvOc1SA4Go9NTEEJ2_jw-l4HE8OTic3yE0X7BhUxEfvV-Xsma2avzYzM1ldzH19_Q2bbKBfQ3lb3Ghyj9ytjRo60Ai9Tzoi2yY7g4yX-fyKvqLvGtFtk1v75uz20DQb3CFfGyjTNpRpLuk6lKmCMsVJUw1laqBMZ1dUQ5l-_9bAmBoY0wbGtA1j2oYxBcjRNRhTA-MHZHp4MBmOrLp7iFW4blhaGOwleZiGLOIz4aWO9KLA4dKRAVjRPuNu4oG97KReEAhbcsF4P_F4Kpk9Cx1HeA_JVpZn4jGhURIxFqawQkkw8JnHgQMnTAITn_VT5rtdQo1kYvhu-JvwTOTVMgZ-DSsiMMXfDAmxyULk-F3ySMsyLnShmdjFGMQgDLokXJNyMwBrw6_fyc4_qBrx2AsMmPyTP8_sKbmz-oOeka1yUYnnQLTL2QsF1p-foeXR |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+consequences+of+sepsis-induced+acute+lung+injury+revealed+by+plasma+%C2%B9H-nuclear+magnetic+resonance+quantitative+metabolomics+and+computational+analysis&rft.jtitle=American+journal+of+physiology.+Lung+cellular+and+molecular+physiology&rft.au=Stringer%2C+Kathleen+A&rft.au=Serkova%2C+Natalie+J&rft.au=Karnovsky%2C+Alla&rft.au=Guire%2C+Kenneth&rft.date=2011-01-01&rft.issn=1522-1504&rft.eissn=1522-1504&rft.volume=300&rft.issue=1&rft.spage=L4&rft_id=info:doi/10.1152%2Fajplung.00231.2010&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-1504&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-1504&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-1504&client=summon |